Santaris
Navigation Links
Santaris in Medical News
Wyeth Pharmaceuticals and Santaris Pharma Announce Strategic Alliance to Develop RNA-based Medicines
COLLEGEVILLE, Pa., & HOERSHOLM, Denmark, Jan. 12 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth (NYSE: WYE ), and Santaris Pharma today announced that the companies have entered into a worldwide strategic alliance to discover, develop and commercialize new medicines bas...Santaris in Medical Technology
Another LNA-based RNA Inhibitor Enters Clinical Trials
... COPENHAGEN, March 20 /PRNewswire/ -- santaris Pharma announced today that the fourth LNA-based d... Survivin inhibitor, which is jointly developed by santaris Pharma and Enzon Pharmaceuticals. The U.S. Food an...lls" http://www.santaris.com About santaris Pharma ......ymphocytic Leukaemia COPENHAGEN, 18 April 2007 - santaris Pharma, the Danish biopharmaceutical company devel...ts at the University of Duisberg-Essen in Germany, santaris researchers reported that white blood cells obtain...tact: Dr. Keith McCullagh President & CEO, santaris Pharma, Tel: +45 4517 9819, Cell:+44 7939 573548...
Santaris Pharma Presents Positive Clinical Data on SPC2996 in Chronic Lymphocytic Leukaemia
...y of Adult Leukaemia Copenhagen, 6th June 2007 - santaris Pharma, the Danish biopharmaceutical company, anno...nd more common tumour type. Dr Lene Worsaae Dalby, santaris Pharma's Vice-President of Clinical Development, s...ntrations. Following this second Phase I/II study, santaris expects to commence randomised Phase II studies in...Santaris in Biological Technology
Santaris Pharma - Interim Report for the Period 1 January to 30 June 2009
... is scheduled to commence in Q3 2009. - santaris Pharma's new lead candidate SPC4955 targeting ...20/344344 ) During the first half of 2009 santaris Pharma continued to make satisfactory progress in ...tis virus replication in the liver. In April 2009, santaris Pharma completed a Phase I First-in-Man single dos...LNA-Based HIF-1 Alpha Inhibitor Shows Early Signs of Clinical Benefit
... COPENHAGEN, June 4 /PRNewswire/ -- santaris Pharma today announced that the cancer drug EZN-29...ha, jointly developed by Enzon Pharmaceuticals and santaris Pharma A/S - was well tolerated and showed early s...edules. The HIF-1 alpha inhibitor is licensed from santaris Pharma A/S. The collaboration between...... COPENHAGEN, June 3 /PRNewswire/ -- santaris Pharma and Copenhagen Institute of Technology, Aal...enmark, announced today that Director of microRNA, santaris Pharma, Sakari Kauppinen, has been appointed Adjun...Sakari Kauppinen, Director of MicroRNA Research at santaris Pharma said: "I feel very honored to be app...
Santaris Pharma Delivers Six LNA-Based RNA Inhibitors to Enzon Pharmaceuticals Ahead of Schedule
...drugs within a short time span," said Henrik 0rum, santaris Pharma's Chief Scientific Officer. santaris Pharma and Enzon Pharmaceuticals signed their agreement in 2006. As part of the agreement santaris Pharma retains the lucrative commercial rights to ...LNA-Based RNA oligonucleotides Potently Inhibit Cancer microRNAs
... COPENHAGEN, April 20 /PRNewswire/ -- santaris Pharma announced today promising findings on the i...ated RNAs, including microRNAs," said Henrik 0rum, santaris Pharma's Chief Scientific Officer. "These results ...rapeutics within a range of disease areas." santaris Pharma is a leader within microRNA research and is...Affitech Appoints Dr. Keith McCullagh as Chairman
...preneurial track record in the biopharmaceutical industry, most recently at santaris Pharma in Denmark, where as CE0 he has played a major role in establishing ...ence industry. Most recently, from October 2003 to June 2008, he was CEO of santaris Pharma, a Danish biopharmaceutical company. From 2000 to 2003 he was execut......y Sector Shanghai, China GammaStar Medical Devices Group Ltd. Hoersholm, Denmark santaris BioPharmaceutical Pharmaceutical California, USA Napo Pharmaceutical BioPharmaceutical ...
... COPENHAGEN, Denmark, Feb. 11 /PRNewswire/ -- santaris Pharma, the Danish biopharmaceutical company devel... February 11th-13th, 2008. A live webcast of the santaris Pharma presentation may be accessed from the news ...ived and available after the presentation. About santaris Pharma ...
Danish Hotspot in Personalized Medicine
...ine in Denmark: Within diagnostics: Dako, Exiqon, FluimediX and Medical Prognostic Institute. Within drug discovery: Genmab, Novo Nordisk, Pharmexa, santaris Pharma and TopoTarget. For further information: Vibeke Dalhoff Tel.:+45-33-26-87-22 +45-61-26-464 email: vda@copcap.com Gitte Pedersen tel...Other TagsRECKABIABIABIABIABIABIABIABIPAIPAIPAIPAIPAIPAIPAIOther Contentsgreengreengreengreengreengreengreengreenbluebluebluebluebluebluebluebluebrachialbrachialbractbreedbreedbreedbreedbranchbranchbranchbranchbranchbranchbranchbronchibronchi
(Date:11/27/2009)...,Nov.27/PRNewswire-FirstCall/--TheGymboreeCorporat...O,willpresentattheNASDAQOMX23rdInvestorProgram,whi...dnesday,December2,2009,at11:45a.m.GMT. ,, Tolis...ntationovertheInternet,pleaselogontowww.gymboree.c...vestorandMediaRelations"andthen"ConferenceCalls&am...
(Date:11/27/2009)...SEINE,France,Nov.27/PRNewswire/--TeamGarmin-Slipst...tedtoethicalsportinganddevelopingthenextgeneration...eamGarmin-TransitionswiththeadditionofTransitionsO...heworld,sleadingmanufacturerofadaptiveeyewear,offe...stselectionofspectaclelensessuchasTransitionslense...
(Date:11/27/2009)... XenaCare Holdings has announced that it has ...ion, one of the largest nonprofit organizations de...ucation. , Delray Beach, ... Inc. (OTCBB: XCHO), a company specializing in the...lthcare products, has announced today that is has ...
(Date:11/27/2009)...ng unprecedented medical, economic burdens, study ...News) -- The number of people with diabetes in the... 25 years, a new study predicts. , That would b...e with the disease, up from 23.7 million today. ,...with diabetes will triple, the study also warns, r...
(Date:11/27/2009)... Voyant Health™ announced today that Sp...d its TraumaCad Enterprise orthopedic templating s.... , (PRWEB) November 27, ...Spectrum Health (Grand Rapids, Michigan) has licen... solution and its TraumaCad Extend workflow soluti...
Breaking Medicine News(10 mins):Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 2Health News:Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend 3[0] The Gymboree Corporation to Present at NASDAQ OMX 23rd Investor Program[0] Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor[0] XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation [0] Diabetes Cases Expected to Double in 25 Years[0] Voyant Health Announces: Spectrum Health Licenses TraumaCad Enterprise and TraumaCad Extend
(Date:11/26/2009)...eir impressive antlers, red deer have been caught ...,s antlers are much more than decorative. They are...lling. John Currey, from The University of York, U... of bone for over half a century and has become fa...rough a long-standing collaboration with Tomas Lan...
(Date:11/26/2009)...llin-resistant Staphylococcus Aureus ) and other ... low-temperature plasma prototype devices have bee...ng bactericidal cocktails. , Two prototype devic...tion of healthy skin (e.g. hands and feet) in hosp...lethal threat; and another to shoot bacteria-killi...
(Date:11/25/2009)...arisch, Head of the Cell Death Research Laboratory...y, has been awarded the prestigious Johnson & John...ng the cause of brain cell damage in Parkinson,s d...cientists in support of innovation and excellence ...conferred earlier this month at an event at the Hy...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Environmental health chief in Milwaukee to hear citizen concerns 10107 1Environmental health chief in Milwaukee to hear citizen concerns 10107 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 1Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 2Research needed to learn which DCIS patients may be candidates for less invasive therapy 10105 3New Hope for Treatment of Pancreatic Cancer 58340 1New Hope for Treatment of Pancreatic Cancer 58340 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |